Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications forteo voluntary patient registry 6 year progress prospective osteosarcoma surveillance
… FORTEO® Post-Market Osteosarcoma Surveillance Program: … to men and younger adults, a prospective, single-arm, patient registry was required. Two comparative studies using Medicare …
… Database and Registry Research Within pharmacoepidemiology research, … Disease prevalence and public health impact Event rates Patient characteristics Treatment patterns and drug … Health Statistics surveys Optum* Regenstrief Institute* Surveillance, Epidemiology and End Results (SEER) cancer …
… Whether you’re looking for consulting advice ; database or registry study; prospective observational research ; a literature review ; or …
… range of data partners, including: Behavioral Risk Factor Surveillance System (BRFSS) CPRD Drug Abuse Warning Network … Database Studies of Left Ventricular Dysfunction (SOLVD) Surveillance, Epidemiology and End Results (SEER) cancer …
… models) Through our network of partners, we have access to patient charts in both developed and emerging markets. From … abstract data from their own patients’ charts based upon patient selection criteria developed by the study team. Our …
Regulatory RWE Consulting As researchers with advanced degrees in epidemiology, public health, biostatistics, and medicine who have hundreds of combined years of applied experience, we can provide you with reliable, informed, and expert consulting advice …
… Analysis of Heterogeneity of Treatment Effects for Patient-Centered Outcomes Let us help you understand your … disease differences—much to the exclusion of individual patient differences. In fact, by design, randomized clinical … Phase I - Identify and define unique responders - Identify patient-reported outcome items/subscales - Power Phase II and …
Causal Inference for Regulatory-Grade RWE Among the hurdles for making your healthcare interventions available to patients is being able to meet regulatory requirements for estimating the product's safety and/or effectiveness using real-world data (RWD). …
… to support your asset. You can develop insights into the patient experience by linking patient-reported outcomes with clinician-reported outcomes. … of results Support for scientific presentations and publications And each step will be delivered with the rigor …
… tumors Non-Hodgkin’s lymphoma Renal cell carcinoma Osteosarcoma Ovarian cancer Pancreatic cancer Peritoneal … in clinical trials Literature reviews Measurement of patient preferences for treatment options Meta-analysis … (PRO) strategy Preparation of HTA submissions Safety surveillance studies Stated preference and willingness-to-pay …